Xiao-Ran Liu (Xiaoran Liu)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 8

Top Venues

British journal of cancer

Cancer medicine

Technology in cancer research & treatment

Peking University Cancer Hospital & Institute

Peking University Cancer Hospital & Institute (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Peking University Cancer Hospital & Institute Aug 01 2014

China

associated researcher :: Department of breast oncology

Education History

Peking University Cancer Hospital & Institute Sep 01 2004 - Jul 01 2014

China

PHD :: Department of breast oncology

Publications

Xiao-Ran Liu, Xiangming Cheng, Feng Xie, Kun Li, Yongcan Shi, Bin Shao, Xu Liang, Fengling Wan, Shidong Jia, Yue Zhang, Yiqiang Liu, Huiping Li
Persistence of peripheral CD8 + CD28- T cells indicates a favourable outcome and tumour immunity in first-line HER2-positive metastatic breast cancer. British journal of cancer 130 (10) (2024)
Xiao-Ran Liu, Xiangming Cheng, Feng Xie, Kun Li, Yongcan Shi, Bin Shao, Xu Liang, Fengling Wan, Shidong Jia, Yue Zhang, Yiqiang Liu, Huiping Li
Persistence of peripheral CD8 + CD28- T cells indicates a favourable outcome and tumour immunity in first-line HER2-positive metastatic breast cancer. British journal of cancer 130 (10) (2024)
Xiao-Ran Liu, Xiangming Cheng, Feng Xie, Kun Li, Yongcan Shi, Bin Shao, Xu Liang, Fengling Wan, Shidong Jia, Yue Zhang, Yiqiang Liu, Huiping Li
Persistence of peripheral CD8 + CD28- T cells indicates a favourable outcome and tumour immunity in first-line HER2-positive metastatic breast cancer. British journal of cancer (2024)
Xiao-Ran Liu, Xiangming Cheng, Feng Xie, Kun Li, Yongcan Shi, Bin Shao, Xu Liang, Fengling Wan, Shidong Jia, Yue Zhang, Yiqiang Liu, Huiping Li
Persistence of peripheral CD8 + CD28- T cells indicates a favourable outcome and tumour immunity in first-line HER2-positive metastatic breast cancer. British journal of cancer 130 (10) (2024)
Xiao-Ran Liu, Xiangming Cheng, Feng Xie, Kun Li, Yongcan Shi, Bin Shao, Xu Liang, Fengling Wan, Shidong Jia, Yue Zhang, Yiqiang Liu, Huiping Li
Persistence of peripheral CD8 + CD28- T cells indicates a favourable outcome and tumour immunity in first-line HER2-positive metastatic breast cancer. British journal of cancer 130 (10) (2024)
Hanfang Jiang, Ruyan Zhang, Xiao-Ran Liu, Ran Ran, Jiayang Zhang, Yaxin Liu, Xinyu Gui, Yifei Chen, Kun Li, Bin Shao, Ying Yan, Xu Liang, Guohong Song, Lijun Di, Huiping Li
Bilateral breast cancer in China: A 10-year single-center retrospective study (2006-2016). Cancer medicine 10 (17) (2021)
Xiao-Ran Liu, Ru-Yan Zhang, Hao Gong, Hope S Rugo, Ling-Bo Chen, Yuan Fu, Jian-Wei Che, Jian Tie, Bin Shao, Feng-Ling Wan, Wei-Yao Kong, Guo-Hong Song, Han-Fang Jiang, Guo-Bing Xu, Hui-Ping Li
Methylome Variation Predicts Exemestane Resistance in Advanced ER+ Breast Cancer. Technology in cancer research & treatment 19 (2020)
Xiao-Ran Liu, Huiping Li, Bin Shao, Jianmin Wu, Weiyao Kong, Guohong Song, Hanfang Jiang, Jing Wang, Fengling Wan
Identification of recurrent BRCA1 mutation and its clinical relevance in Chinese Triple-negative breast cancer cohort. Cancer medicine 6 (3) (2017)

Xiao-Ran Liu.css-eqlu8i{font-size:small;padding-left:4px;} (Xiaoran Liu)

Publication Activity (10 Years)

Top Topics

Top Venues

Xiao-Ran Liu (Xiaoran Liu)